Edgar Hull
Medical Oncology · Pascagoula, MSNPI 1063628808
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,831 and has fallen 98.2% since, to $34 in 2021. That places this record below the midpoint for medical oncology clinicians in MS, where the typical reported total is $7,285.
Across 140 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$327
- Novartis$290
- Merck$200
- Johnson & Johnson$175
- AstraZeneca$132
- Pharmacyclics LLC, An Abbvie Company$100
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,25799%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 22 | $327 |
| Novartis | 16 | $290 |
| Merck | 13 | $200 |
| Johnson & Johnson | 8 | $175 |
| AstraZeneca | 9 | $132 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $100 |
| Amgen | 5 | $98 |
| Astellas Pharma US Inc | 5 | $92 |
| Bristol Myers Squibb | 5 | $89 |
| Ipsen Biopharmaceuticals, Inc | 3 | $69 |
| Incyte Corporation | 4 | $66 |
| Sanofi | 4 | $59 |
| AbbVie | 4 | $57 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| Daiichi Sankyo Inc. | 3 | $49 |
| Pfizer | 4 | $49 |
| Genentech USA, Inc. | 3 | $46 |
| Bayer | 3 | $43 |
| Verastem, Inc. | 3 | $43 |
| EMD Serono, Inc. | 2 | $29 |
| Seagen Inc. | 2 | $28 |
| Tesaro, Inc. | 2 | $27 |
| Puma Biotechnology, Inc. | 2 | $24 |
| Biocompatibles, Inc. | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Dova Pharmaceuticals | 1 | $13 |
| Myriad Genetic Laboratories, Inc. | 1 | $13 |
| Pharmacosmos Therapeutics Inc. | 1 | $13 |
| EUSA Pharma (US) LLC | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
How this compares
$2,270 in reported general payments places this provider in the 20th percentile of 20 medical oncology providers in Mississippi.
Other medical oncology in Pascagoula
- Brian PersingPascagoula$263K
- Techksell WashingtonPascagoula$7K
- James ClarksonPascagoula$2K
- James ThigpenJackson$41K
- Olivia HightowerGulfport$23K
- Sidra KhalidGulfport$19K
- Stephanie FussellGulfport$13K
- Tammy YoungJackson$12K
- Elizabeth HerringtonJackson$10K
- Suhail ObajiNew Albany$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.